课题基金 / 基金详情

项目摘要

项目成果

BRIAN S SCHAFFHAUSEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mechanisms of fundamental importance for tumor development and growth have been repeatedly uncovered by studying polyomaviruses. Tyrosine kinase activity, phosphoinositide 3-kinase (PI3K) activity and the tumor suppressor p53 were all discovered there. We have recently discovered that one viral oncogene, small T (PyST), can regulate survival in many different cells by causing or by preventing apoptosis. To switch between killing and promoting survival PyST uses the important cellular phosphatase PP2A. Which of the many PP2A species required for this life and death determination will be determined. One key target of PyST/PP2A action is the cellular kinase Akt. Since Akt is generally viewed as a pro-survival protein, the observation that it can be an apoptotic stimulus is quite provocative. PyST/PP2A modulates Akt phosphorylation on its T308 and S473 regulatory sites. The result is a differential alteration in the phosphorylation of Akt substrates. The role for Akt in general and for the asymmetric phosphorylation in particular will be confirmed. Akt substrates will be examined for their role in cell killing. It is likely that additional targets besides Akt are important for PyST killing. Non-biased screens will be performed to identify other pathways that are involved. The most likely direct targets would be ones that PyST binds and brings together with PP2A. New PyST binding proteins that might be required for cell killing will be identified. An advantage of murine polyomavirus is that signal transduction hypotheses can be tested in mice. We have uncovered a trick that will allow us to compare a virus that has PyST to one that does not. Whether PyST is required for virus growth and more importantly how it contributes to the polyoma tumor profile will be tested. The hypothesis that PyST/PP2A can function as a tumor suppressor in some tissues will be examined using liver as a model. The outcome of this work will be a fuller understanding of how PP2A and Akt participate in life and death decisions. It should illuminate new signal transduction mechanisms. In the future the knowledge gained here might allow us to decrease the survival of cancer cells selectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROJECT 3: Pathways Controlled by PP2A A-Beta in Normal, Transformed and Tumor Cells
  • 批准号:
    10227784
  • 项目类别:
  • 资助金额:
    $35.42万
  • 财政年份:
    2017
  • 负责人:
    BRIAN S SCHAFFHAUSEN
  • 依托单位:
PROJECT 3: Pathways Controlled by PP2A A-Beta in Normal, Transformed and Tumor Cells
  • 批准号:
    9981672
  • 项目类别:
  • 资助金额:
    $35.42万
  • 财政年份:
    2017
  • 负责人:
    BRIAN S SCHAFFHAUSEN
  • 依托单位:
The Role of Polyoma Small T in Regulating Cell Survival
  • 批准号:
    8233030
  • 项目类别:
  • 资助金额:
    $56.17万
  • 财政年份:
    2011
  • 负责人:
    BRIAN S SCHAFFHAUSEN
  • 依托单位:
Products of the Transforming Genes of Polyomavirus
  • 批准号:
    6989675
  • 项目类别:
  • 资助金额:
    $33.85万
  • 财政年份:
    2004
  • 负责人:
    BRIAN S SCHAFFHAUSEN
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: